Doxorubicin

Assessing patency of an implanted port

Assessing patency of an implanted port

By

How should a fibrin overgrowth on an internal catheter be managed when there is no blood return from the implanted port?

Targeting mitochondrial enzyme may reduce cardiac effects from chemotherapy drug

By

Investigators have identified two compounds that appear to block the cardiac damage caused by doxorubicin. Their report indicates that inhibiting the action of an enzyme key to the generation of cellular energy in mitochondria could prevent doxorubicin-induced damage to cardiac cells without reducing the drug's antitumor effects.

Doxorubicin cardiotoxicity is associated with mitochondria-accumulating iron

By

Doxorubicin accumulates within the mitochondria of cardiomyocytes and this accumulation promotes mitochondrial production of reactive oxygen species (ROS) and the accumulation of iron.

Use of MUGA scans before initiating treatment

Use of MUGA scans before initiating treatment

By

Oncology nursing literature states that a MUGA scan must be obtained prior to initiating cardiotoxic chemotherapies. When should the scan be obtained?

Doxil shortage speeds approval of generic version

After expedited review, the FDA okays the first generic version of Doxil (doxorubicin hydrochloride liposome injection), now in short supply.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs